| EVs | Extracellular vesicles |
| AADs | Age-associated diseases |
| SASP | Senescence-associated secretory phenotype |
| AD | Alzheimer’s disease |
| SLE | Systemic lupus erythematosus |
| HUVECs | Human umbilical vein endothelial cells |
| TSAP6 | Tumor suppressor-activated pathway 6 |
| PARP | Poly ADP ribose polymerase |
| PD-L1 | Programmed death-ligand 1 |
| ROS | Reactive oxygen species |
| PMNs | Polymorphonuclear cells |
| CVD | Cardiovascular disease |
| BBB | Blood–brain barrier |
| RPE | Retinal pigment epithelial |
| LRAT | Lecithin retinol acyltransferase |
| RPE65 | Retinoid isomerase |
| RDH5 | Retinol dehydrogenase 5 |
| MOG | Myelin oligodendrocyte glycoprotein |
| CAD | Coronary artery disease |
| MetS | Metabolic syndrome |
| VEGF | Vascular endothelial growth factor |
| MenSCs | Menstrual blood-derived SCs |
| PBMCs | Peripheral blood mononuclear cells |
| CKD | Chronic kidney disease |
| HLSCs | Human liver stem-like cells |
| AMPK | Adenosine monophosphate-activated protein kinase |
| PDX-1 | Pancreatic and duodenal homeobox 1 |
| CCL2 | Chemokine ligand-2 |
| VEGF | Vascular endothelial growth factor |
| ALI | Acute lung injury |
| IBD | Inflammatory bowel disease |
| ANPs | Artificial nanoparticles |
| TNF-α | Tumor necrosis factor alpha |
| PTK | Protein tyrosine kinase |